We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer.AuthorsKo AH; Venook AP; Bergsland EK; Kelley RK; Korn WM; Dito E; Schillinger B; Scott J; Hwang J; Tempero MAPublicationCancer chemotherapy and pharmacology, 2010, Vol 66, Issue 6, p1051ISSN1432-0843Publication typearticleDOI10.1007/s00280-010-1257-5